---
accession : E-GEOD-13827
platform  : A-AFFY-44
pathway   : MAPK
cells     : human melanocyte
treatment : activated BRAF
effect    : activating
hours     : 120

control   :
    - GSE13827GSM347901
    - GSE13827GSM347902
treatment :
    - GSE13827GSM347899
    - GSE13827GSM347900
...
